United States · FDA National Drug Code directory
LOTEPREDNOL ETABONATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60219-1362_0e87ba50-9918-4733-8ed3-95ce3c772b07
- Product NDC
- 60219-1362
- Form
- SUSPENSION/ DROPS
- Composition / generic term
- loteprednol etabonate
- Labeler
- Amneal Pharmaceuticals NY LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250522
- Source listing expiry
- 20261231
Source-listed ingredients
- LOTEPREDNOL ETABONATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (60219-1362-1) / 5 mL in 1 BOTTLE · 60219-1362-1
- 1 BOTTLE in 1 CARTON (60219-1362-2) / 10 mL in 1 BOTTLE · 60219-1362-2
- 1 BOTTLE in 1 CARTON (60219-1362-3) / 15 mL in 1 BOTTLE · 60219-1362-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →